Abbreviated dual antiplatelet therapy after percutaneous coronary intervention using third-generation stents remained noninferior vs. 12-month DAPT for non-ST-segment elevation myocardial infarction ...

Vienna, Austria - One of the largest studies to date looking at the impact of stent thrombosis and its treatment suggests that once thrombosis occurs, it matters very little whether the culprit was a ...

Intraprocedural stent thrombosis is a relatively rare complication of percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS), occurring less than 1% of of the time, ...

Please provide your email address to receive an email when new articles are posted on . PCI for in-stent chronic total occlusion had similar success rates and in-hospital complications compared with ...

In patients with three-vessel and/or left main coronary artery disease (CAD), percutaneous coronary intervention (PCI) with paclitaxel-eluting stents is equivalent to coronary artery bypass grafting ...

For example, in the CTO setting, “IVUS can facilitate proximal cap puncture, subintimal navigation, and reentry, whereas OCT ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window For percutaneous ...

A study, published in The New England Journal of Medicine, compared drug-eluting bioresorbable vascular scaffolds with drug-eluting metallic stents in percutaneous coronary interventions. Abbott ...

Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not superior to dual-antiplatelet therapy (DAPT) for major bleeding but is non-inferior for ...